Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)

Clinical trial NCT02959489 · COMPLETED

Trial details

NCT number: NCT02959489
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Alzheimer Disease Amyloid Beta-Peptides Risk Assessment Education Neuropsychological Tests Neuroimaging

Start date: 2016-11-01
Primary completion: 2020-05-13
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.